돌아가기
Huagongshe화공사 화학 정보 인쇄 보고서 · 연구 참고용
HRID 1922809생성일: 2026년 10월 26일

Acetic Acid → 1-[2-(2-Chloro-9-methyl-6-morpholin-4-yl-9H-purin-8-yl)ethyl]-4-methylpiperidin-4-ol

https://huagongshe.com/reaction/1922809

반응식

참여 물질

역할이름HCID투입량
반응물Acetic AcidHCID 176—
반응물Trimethyl orthoformateHCID 9005—
반응물Sodium triacetoxyborohydrideHCID 5049666—
반응물4-Methylpiperidin-4-olHCID 15649174—
반응물(2-chloro-9-methyl-6-morpholin-4-yl-9H-purin-8-yl)acetaldehydeHCID 59605819—
용매1,2-DichloroethaneHCID 11—
생성물1-[2-(2-Chloro-9-methyl-6-morpholin-4-yl-9H-purin-8-yl)ethyl]-4-methylpiperidin-4-olHCID 5960590717%

반응 단계

To a solution of (2-chloro-9-methyl-6-morpholin-4-yl-9H-purin-8-yl)acetaldehyde (200 mg, 0.68 mmol) in DCE (15 mL) was added 4-methylpiperidin-4-ol (117 mg, 1.01 mmol), trimethyl orthoformate (0.74 mL, 6.76 mmol) and acetic acid (0.04 mL, 0.68 mmol). The reaction mixture was stirred at room temperature for 1.5 h, sodium triacetoxyborohydride (187 mg, 1.35 mmol) was added and the resulting mixture stirred for a further 18 h. The reaction mixture was loaded onto an Isolute® SCX-2 cartridge, washed with MeOH then the desired product eluted with 2 M NH3/MeOH in DCM. The resulting residue was purified by column chromatography (Si—PCC, 0-20% 2 M NH3/MeOH in DCM) to give the title compound as a colourless oil (45 mg, 17%). LCMS (Method H): RT=2.24 min, [M+H]+ 395.5

출처 및 근거

DOI10.6084/m9.figshare.5104873.v1
특허 번호US08173650B2
출처 데이터셋uspto-grants-2012_05
ORD IDord-cd493ad662aa4d998c0c83042c245a9f
출처 메모uspto-grants-2012_05